| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Magainin Pharmaceuticals, Inc., and Magainin Research Institute, Plymouth Meeting, Pennsylvania 19142
Linear helical channel-forming peptides structurally similar to the Xenopus-derived antibiotic, Magainin2-amide, were synthesized. Because activity resides in the physicochemical properties of the peptides, an all-D-amino acid as well as an all-L-amino acid sequence were tested for anticancer activity. In vitro activity against carcinoma cells and in vivo efficacy against four murine ascites tumors were determined. The novel peptides proved to have enhanced potency in vitro and in vivo as compared to the parent compound. The 50% inhibitory concentrations against A549 cells for the all-D, the all-L, and Magainin2 were 6, 10, and 110 µg/ml, respectively. All three peptides had activity against P388 leukemia, S180 ascites, and a spontaneous ovarian tumor when injected i.p. Increase in life span of over 100% was produced for the analogues in the latter two models. The maximally effective concentrations for the analogues were 20 to 25 mg/kg while Magainin2 required 50–60 mg/kg for in vivo efficacy. The all-D-amino acid peptide, MSI-238, proved as effective as doxorubicin at a more advanced stage of the ovarian tumor and this activity may be attributed to its resistance to proteolytic degradation. Therefore, this class of amphiphilic 
-helical cationic peptides has potential in the peritoneal treatment of ovarian cancer.
1 To whom requests for reprints should be addressed.
Received 12/30/92. Accepted 4/28/93.
This article has been cited by other articles:
|
|
 |
|
  J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells Am. J. Pathol., November 1, 2006; 169(5): 1753 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Papo, D. Seger, A. Makovitzki, V. Kalchenko, Z. Eshhar, H. Degani, and Y. Shai Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic Peptide. Cancer Res., May 15, 2006; 66(10): 5371 - 5378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Lemeshko, M. Arias, and S. Orduz Mitochondria Permeabilization by a Novel Polycation Peptide BTM-P1 J. Biol. Chem., April 22, 2005; 280(16): 15579 - 15586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Mangoni, J. M. Saugar, M. Dellisanti, D. Barra, M. Simmaco, and L. Rivas Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity J. Biol. Chem., January 14, 2005; 280(2): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Papo, A. Braunstein, Z. Eshhar, and Y. Shai Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic D-, L-Amino Acid Peptide: Membrane Lysis, Increased Necrosis, and Inhibition of Prostate-Specific Antigen Secretion Cancer Res., August 15, 2004; 64(16): 5779 - 5786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Papo, M. Shahar, L. Eisenbach, and Y. Shai A Novel Lytic Peptide Composed of DL-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice J. Biol. Chem., May 30, 2003; 278(23): 21018 - 21023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhao and P. K. J. Kinnunen Modulation of the Activity of Secretory Phospholipase A2 by Antimicrobial Peptides Antimicrob. Agents Chemother., March 1, 2003; 47(3): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takeshima, A. Chikushi, K.-K. Lee, S. Yonehara, and K. Matsuzaki Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes J. Biol. Chem., January 3, 2003; 278(2): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Mystkowska, A. Niemierko, A. Komar, and W. Sawicki Embryotoxicity of magainin-2-amide and its enhancement by cyclodextrin, albumin, hydrogen peroxide and acidification Hum. Reprod., July 1, 2001; 16(7): 1457 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Scott, C. M. Rosenberger, M. R. Gold, B. B. Finlay, and R. E. W. Hancock An {alpha}-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression J. Immunol., September 15, 2000; 165(6): 3358 - 3365. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
